Alan Wake 2 has recouped most of its development and marketing costs, according to Remedy’s CEO Tero Virtala, though it has yet to break even. The company reported a 129% revenue increase in September 2024 compared to the previous year. Remedy has secured funding for upcoming projects, including Control 2 and the Max Payne remakes. While initial profits from Control won’t benefit Remedy significantly due to a lack of publisher support, they expect greater financial gains post-release.
—
Alan Wake 2 a récupéré la plupart de ses coûts de développement et de marketing, selon le PDG de Remedy, Tero Virtala, bien qu’il n’ait pas encore atteint le seuil de rentabilité. La société a signalé une augmentation de 129 % de ses revenus en septembre 2024 par rapport à l’année précédente. Remedy a obtenu un financement pour ses projets à venir, dont Control 2 et les remakes de Max Payne. Bien que les bénéfices initiaux de Control ne profitent pas beaucoup à Remedy en raison d’un manque de soutien de l’éditeur, ils s’attendent à des gains financiers plus importants après la sortie.
Remedy’s CEO Tero Virtala recently announced that their title Alan Wake 2 has now ‘recovered a significant portion of its development and marketing costs’ in a financial review covering January to September 2024. As someone who eagerly anticipates more installments in the Alan Wake series, or at the very least, unique and high-quality single-player horror games, I find this news both encouraging and a bit concerning. The game’s release in October 2023 hasn’t yet achieved profitability.
It’s noteworthy that the financial report was compiled prior to the launch of Alan Wake 2’s Lake House expansion and the Physical Deluxe Edition. This suggests that these additions may have contributed positively to the game’s financial performance since the data collection occurred.
The overall financial trajectory of Remedy appears to be improving, with a remarkable 129% increase in revenue for July to September 2024 compared to the same timeframe in the previous year, reaching 17.9 million Euros, and yielding an operating profit of 2.4 million euros.
To bolster their finances, Remedy has undertaken several initiatives. Annapurna is providing funding for half of Control 2’s development in exchange for rights to adapt the Control and Alan Wake franchises into film and television. Moreover, Remedy has secured a convertible loan agreement worth 15 million euros with Tencent. They anticipate even better financial results leading up to their next report.
The financial review also provided updates on various Remedy projects currently under development. The newly announced three-player spin-off shooter, FBC: Firebreak, is being positioned as a ‘mid-priced’ game and is already in full production, focusing on refining the core gameplay loop and improving user interface elements based on feedback from playtesting. Additionally, the remakes of Max Payne 1 and 2, created in collaboration with Rockstar, are now progressing steadily in full production.
Control 2 is also on the horizon, with story hints introduced in Alan Wake 2’s Lake House DLC. Virtala shared that Control 2 is moving forward smoothly through the production readiness phase and is scheduled to enter full production in 2025. Many essential elements are already in place to minimize production risks, with workflows and pipelines being tested in anticipation of the upcoming full production phase.
The original Control has proven to be a commercial hit for Remedy, with four million copies sold as of February 2024. That same month, Remedy acquired the rights to self-publish any future Control titles from the original publisher, 505 Games. In his latest financial review, Virtala cautioned investors that while Remedy will initially earn less from its Control projects due to the absence of a publisher’s financial support, the potential for greater earnings post-release exists, as there will be no publisher taking a percentage.
As someone not well-versed in finance, I have some pressing questions: 1) Does the commercial performance of Alan Wake 2 align with Remedy’s expectations? 2) If not, what strategies is the company implementing to sustain the development of unique horror experiences like this?
Le PDG de Remedy, Tero Virtala, a récemment annoncé que leur titre Alan Wake 2 a désormais ‘récupéré une part importante de ses coûts de développement et de marketing’ dans un examen financier couvrant la période de janvier à septembre 2024. En tant que personne qui attend avec impatience d’autres épisodes de la série Alan Wake, ou à tout le moins, des jeux d’horreur uniques et de haute qualité en solo, je trouve cette nouvelle à la fois encourageante et quelque peu préoccupante. La sortie du jeu en octobre 2023 n’a pas encore atteint la rentabilité.
Il est à noter que le rapport financier a été compilé avant le lancement de l’extension Lake House d’Alan Wake 2 et de l’édition Deluxe physique. Cela suggère que ces ajouts peuvent avoir contribué positivement à la performance financière du jeu depuis la collecte des données.
La trajectoire financière globale de Remedy semble s’améliorer, avec une augmentation remarquable de 129 % des revenus pour la période de juillet à septembre 2024 par rapport à la même période de l’année précédente, atteignant 17,9 millions d’euros, et générant un bénéfice opérationnel de 2,4 millions d’euros.
Pour renforcer ses finances, Remedy a entrepris plusieurs initiatives. Annapurna finance la moitié du développement de Control 2 en échange des droits d’adapter les franchises Control et Alan Wake au cinéma et à la télévision. De plus, Remedy a obtenu un prêt convertible de 15 millions d’euros auprès de Tencent. Ils anticipent d’obtenir de meilleurs résultats financiers en prévision de leur prochain rapport.